Logotype for Philip Morris International Inc

Philip Morris International (PM) Q3 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Philip Morris International Inc

Q3 2024 earnings summary

19 Jan, 2026

Executive summary

  • Delivered record Q3 2024 results with double-digit organic growth in revenue, operating income, and EPS, driven by strong performance across all business segments, especially smoke-free products and ZYN nicotine pouches.

  • Raised full-year 2024 guidance for volume, organic sales growth, operating income, and EPS, reflecting broad-based acceleration in IQOS, ZYN, and combustibles.

  • Net revenues for the nine months ended September 30, 2024, increased 7.8% to $28.2B, with smoke-free products accounting for 38.2% of net revenues.

  • Operating income rose 17.0% to $10.1B, and net earnings attributable to PMI surged 35.9% to $7.6B, with diluted EPS up 35.5% to $4.89.

  • Key events included a $198M Vectura impairment, full U.S. IQOS rights acquisition, and ongoing regulatory, litigation, and geopolitical risks.

Financial highlights

  • Q3 2024 organic net revenues grew 11.6% year-over-year to $9.9B, with operating income up 13.8% and adjusted diluted EPS up 14.4% to $1.91, or 18% excluding currency.

  • Gross profit increased 13.0% overall, with smoke-free gross profit up 20.2% and combustibles up 8.7%.

  • Nine-month net revenues up 7.8% to $28.2B; net earnings attributable to PMI up 35.9% to $7.6B.

  • Net cash from operating activities reached $8.2B for nine months, up from $5.9B in 2023.

  • Dividend increased 3.8% to $1.35 per share quarterly ($5.40 annualized).

Outlook and guidance

  • Raised 2024 shipment volume growth outlook to 2–3%, with adjusted IMS HTU volume growth of around 13%.

  • Organic net revenue growth forecast increased to around 9.5%, with smoke-free net revenue expected to reach nearly $15B.

  • Adjusted organic operating income growth forecast raised to 14–14.5%; adjusted diluted EPS forecast at $6.45–$6.51, including a $0.40 currency headwind.

  • Net cash from operating activities for 2024 expected to be approximately $11B; capex of ~$1.4B.

  • No share repurchases in 2024; net debt/adjusted EBITDA ratio targeted at ~2x by end of 2026.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more